Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TumorGlow for Intraoperative Imaging of Sarcoma Lung Metastases in Pediatrics
NCT07658768Phase 1Recruiting
- Sponsor
- Abramson Cancer Center
- Start
- Jul 2026
- Primary completion
- May 2027
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of indocyanine green in sarcoma, sponsored by Abramson Cancer Center. Primary endpoint: Number of Participants with Adverse Events (AEs) and Serious Adverse Events (SAEs) at 1 year. Started Jul 2026; status: recruiting.
02
Drugs
indocyanine green
03
Conditions
sarcoma
Beyond the preview
Go deeper on NCT07658768.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07658768.